Evidence map›Paper›PMID 18955267›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2010

In vitro Evaluation of the Antiviral Activity of an Extract of Date Palm (Phoenix dactylifera L.) Pits on a Pseudomonas Phage.

Sabah A A Jassim, Mazen A Naji

Abstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Date palm fruits (Frontiers in plant science · 2026
    Review
  3. Nutraceuticals ofDrug design, development and therapy · 2026
    Review
  4. Network Pharmacology andCurrent pharmaceutical design · 2025
    Article
  5. Ajwa date extract (Saudi medical journal · 2025
    Article
  6. Phytochemical profiling ofRSC advances · 2024
    Article
  7. Article
  8. Article
  9. Date Palm Fruit (Nutrients · 2023
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Anti-inflammatory activity of date palm seed by downregulating interleukin-1β, TGF-β, cyclooxygenase-1 and -2: A study among middle age women.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
  18. Phytotherapeutic potential and pharmaceutical impact ofJournal of food science and technology · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sabah A A JassimDepartment of Microbiology, Zayed Complex for Herbal Research and Traditional Medicine, General Authority for Health Services for the Emirate of Abu Dhabi.
Mazen A Naji

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A crude acetone extract of the pit of date palm (Phoenix dactylifera L.) was prepared and its antiviral activity evaluated against lytic Pseudomonas phage ATCC 14209-B1, using Pseudomonas aeruginosa ATCC 25668 as the host cell. The antiviral activity of date pits was found to be mediated by binding to the phage, with minimum inhibitory concentration (MIC) of <10 μg ml(-1). The decimal reduction time (D-values), the concentration exponent (η) and the phage inactivation kinetics were determined. The date pit extracts show a strong ability to inhibit the infectivity of Pseudomonas phage ATCC 14209-B1 and completely prevented bacterial lysis, which it is hoped will promote research into its potential as a novel antiviral agent against pathogenic human viruses.

Indexed as

antiviralbacteriophageCAMMICphagePhoenix dactylifera LPseudomonas aeruginosa

Identifiers

PMID18955267
PMCPMC2816388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.